Tau negative frontal lobe dementia at 17q21: significant finemapping of the candidate region to a 4.8 cM interval
- PMID: 12476321
- DOI: 10.1038/sj.mp.4001198
Tau negative frontal lobe dementia at 17q21: significant finemapping of the candidate region to a 4.8 cM interval
Abstract
We report the results of a genome-wide search in a four-generation pedigree with autosomal dominant early-onset dementia (mean onset age: 64.9 years, range 53-79 years). In this family we previously excluded the known Alzheimer's disease genes based on linkage analysis and mutation screening of the amyloid precursor protein gene (exons 16 and 17) and the presenilin 1 and 2 genes. In addition we excluded mutations in the prion protein gene and exons 9-13 of the microtubule associated protein tau (MAPT) gene. We obtained conclusive linkage with chromosome 17q21 markers with a maximum multi-point LOD score of 5.51 at D17S951 and identified a candidate region of 4.8 cM between D17S1787 and D17S958 containing MAPT. Recent clinical and neuropathological follow-up of the family showed that the phenotype most closely resembled frontotemporal dementia (FTD) characterized by dense ubiquitin-positive neuronal inclusions that were tau negative. Extensive mutation analysis of MAPT identified 38 sequence variations in exons, introns, untranslated regions and the 5' regulatory sequence, however none was comprised within the disease haplotype. Although our findings do not entirely exclude a mutation in a yet unanalyzed region of MAPT, the apparent absence of MAPT mutations combined with the lack of tau pathology is highly suggestive for another defective gene at 17q21 responsible for FTD in this family.
Similar articles
-
A Belgian ancestral haplotype harbours a highly prevalent mutation for 17q21-linked tau-negative FTLD.Brain. 2006 Apr;129(Pt 4):841-52. doi: 10.1093/brain/awl029. Epub 2006 Feb 22. Brain. 2006. PMID: 16495329
-
Tau is a candidate gene for chromosome 17 frontotemporal dementia.Ann Neurol. 1998 Jun;43(6):815-25. doi: 10.1002/ana.410430617. Ann Neurol. 1998. PMID: 9629852
-
Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21.Nature. 2006 Aug 24;442(7105):920-4. doi: 10.1038/nature05017. Epub 2006 Jul 16. Nature. 2006. PMID: 16862115
-
The role of tau (MAPT) in frontotemporal dementia and related tauopathies.Hum Mutat. 2004 Oct;24(4):277-95. doi: 10.1002/humu.20086. Hum Mutat. 2004. PMID: 15365985 Review.
-
[The amyloid and tau hypothesis in degenerative dementia].Tidsskr Nor Laegeforen. 1999 Mar 10;119(7):976-9. Tidsskr Nor Laegeforen. 1999. PMID: 10210960 Review. Norwegian.
Cited by
-
Pathological heterogeneity of frontotemporal lobar degeneration with ubiquitin-positive inclusions delineated by ubiquitin immunohistochemistry and novel monoclonal antibodies.Am J Pathol. 2006 Oct;169(4):1343-52. doi: 10.2353/ajpath.2006.060438. Am J Pathol. 2006. PMID: 17003490 Free PMC article.
-
The two faces of protein misfolding: gain- and loss-of-function in neurodegenerative diseases.EMBO J. 2008 Jan 23;27(2):336-49. doi: 10.1038/sj.emboj.7601930. EMBO J. 2008. PMID: 18216876 Free PMC article. Review.
-
Clinical phenotypes and genetic biomarkers of FTLD.J Neural Transm (Vienna). 2012 Jul;119(7):851-60. doi: 10.1007/s00702-012-0804-0. Epub 2012 Apr 19. J Neural Transm (Vienna). 2012. PMID: 22527778 Review.
-
Recent insights into the involvement of progranulin in frontotemporal dementia.Curr Neuropharmacol. 2011 Dec;9(4):632-42. doi: 10.2174/157015911798376361. Curr Neuropharmacol. 2011. PMID: 22654721 Free PMC article.
-
Clinical and Neuroimaging Aspects of Familial Frontotemporal Lobar Degeneration Associated with MAPT and GRN Mutations.Adv Exp Med Biol. 2021;1281:77-92. doi: 10.1007/978-3-030-51140-1_6. Adv Exp Med Biol. 2021. PMID: 33433870 Review.
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical